Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mutational analysis of the putative fusion domain of Ebola virus glycoprotein.

Journal of virology·1999

Same author

Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents.

Antimicrobial agents and chemotherapy·1999

Same author

Hyperenhancing focal liver lesions: differential diagnosis with helical CT.

AJR. American journal of roentgenology·1999

Same author

Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.

International journal of pharmaceutics·1999

Same author

Post-weaning multisystemic wasting syndrome in Spain.

The Veterinary record·1999

Same author

[Congenital defects of antithrombin III and proteins C and S during pregnancy].

Revista medica de Chile·1999

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Published on: July 8, 2011

Knocking down gene expression with dendritic vectors.

M Raviña¹, P Paolicelli, B Seijo

¹Department of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain.

Mini Reviews in Medicinal Chemistry

|April 13, 2010

Summary

This summary is machine-generated.

Dendritic polymers show great potential for antisense delivery. Modifications enhance their efficacy and safety, advancing this promising nucleic acid therapy technology.

More Related Videos

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro

Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro

Published on: March 7, 2022

Related Experiment Videos

Last Updated: Jun 14, 2026

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Published on: July 8, 2011

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro

Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro

Published on: March 7, 2022

Area of Science:

Polymer Chemistry
Biotechnology
Drug Delivery Systems

Background:

Antisense technology utilizes nucleic acid sequences to modulate gene expression.
Effective delivery of antisense agents is a major challenge in nucleic acid therapies.
Dendritic polymers offer unique structural properties for therapeutic applications.

Purpose of the Study:

To review the potential of dendritic polymers for antisense delivery.
To highlight various dendritic structures and their modifications for improved performance.
To discuss the adaptation of dendritic polymer chemistry for antisense delivery requirements.

Main Methods:

Literature review of dendritic polymer synthesis and applications in antisense delivery.
Analysis of structural modifications to dendritic polymers.
Evaluation of reported efficacy and safety data.

Main Results:

Various dendritic polymer architectures have been explored for antisense delivery.
Chemical modifications significantly improve the efficacy and safety profile of these systems.
Dendritic polymers demonstrate tunable properties suitable for specific antisense delivery needs.

Conclusions:

Dendritic polymers represent a promising platform for advanced antisense delivery systems.
Further research into dendritic polymer design can optimize therapeutic outcomes.
This technology holds potential for developing novel gene silencing therapies.